DK0445894T3 - Anvendelse af tumornekrosefaktor - Google Patents

Anvendelse af tumornekrosefaktor

Info

Publication number
DK0445894T3
DK0445894T3 DK91200520.4T DK91200520T DK0445894T3 DK 0445894 T3 DK0445894 T3 DK 0445894T3 DK 91200520 T DK91200520 T DK 91200520T DK 0445894 T3 DK0445894 T3 DK 0445894T3
Authority
DK
Denmark
Prior art keywords
necrosis factor
tumor necrosis
disease
demyelinatig
uveitis
Prior art date
Application number
DK91200520.4T
Other languages
English (en)
Inventor
Yoshiki Otsuka
Kazuyoshi Hori
Hiroshi Hayashi
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2056734A external-priority patent/JPH03261726A/ja
Priority claimed from JP2056736A external-priority patent/JPH03261725A/ja
Priority claimed from JP2056735A external-priority patent/JPH03261724A/ja
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of DK0445894T3 publication Critical patent/DK0445894T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Telephonic Communication Services (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Medicines Containing Plant Substances (AREA)
DK91200520.4T 1990-03-09 1991-03-08 Anvendelse af tumornekrosefaktor DK0445894T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2056734A JPH03261726A (ja) 1990-03-09 1990-03-09 ぶどう膜炎治療用医薬組成物
JP2056736A JPH03261725A (ja) 1990-03-09 1990-03-09 移植片対宿主の疾患治療用医薬組成物
JP2056735A JPH03261724A (ja) 1990-03-09 1990-03-09 脱髄性疾患治療用医薬組成物

Publications (1)

Publication Number Publication Date
DK0445894T3 true DK0445894T3 (da) 1995-04-03

Family

ID=27296018

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91200520.4T DK0445894T3 (da) 1990-03-09 1991-03-08 Anvendelse af tumornekrosefaktor

Country Status (11)

Country Link
US (1) US5190750A (da)
EP (1) EP0445894B1 (da)
AT (1) ATE118221T1 (da)
AU (1) AU633196B2 (da)
CA (1) CA2037831C (da)
DE (2) DE69107226T2 (da)
DK (1) DK0445894T3 (da)
ES (1) ES2067842T3 (da)
FR (1) FR2659235A1 (da)
GB (1) GB2241891B (da)
GR (1) GR3015840T3 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5080393A (en) * 1992-08-17 1994-03-15 Autoimmune, Inc. Bystander suppression of retroviral-associated neurological disease
HUT76101A (en) * 1994-04-08 1997-06-30 Brigham & Womens Hospital Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
DK1076703T4 (da) * 1998-05-15 2011-03-28 Genentech Inc Terapeutiske anvendelser af IL-17-homologe polypeptider

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292727A (ja) * 1986-06-12 1987-12-19 Dainippon Pharmaceut Co Ltd 癌壊死因子を有効成分とする鎮痛・消炎剤
JPS6330426A (ja) * 1986-07-25 1988-02-09 Mitsubishi Chem Ind Ltd 自己免疫性疾患治療薬
DE3631413A1 (de) * 1986-09-16 1988-03-24 Knoll Ag Therapeutisches system zur lokalen applikation von pharmawirkstoffen
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US4963354A (en) * 1987-01-21 1990-10-16 Genentech, Inc. Use of tumor necrosis factor (TNF) as an adjuvant
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
AU2844889A (en) * 1988-01-22 1989-07-27 Collagen Corporation Method for suppressing the growth of normal and cancer cells
DE3839639A1 (de) * 1988-11-24 1990-05-31 Basf Ag Verwendung von tnf bei der behandlung von hautkrankheiten
CA2003981C (en) * 1988-12-27 2000-06-13 Hiroshi Ishimaru Pharmaceutical compositions and use thereof in the treatment of psoriasis

Also Published As

Publication number Publication date
ES2067842T3 (es) 1995-04-01
CA2037831C (en) 1997-01-21
DE69107226T2 (de) 1995-05-24
CA2037831A1 (en) 1991-09-10
GB2241891A (en) 1991-09-18
US5190750A (en) 1993-03-02
AU633196B2 (en) 1993-01-21
EP0445894A3 (en) 1992-01-02
DE4107554A1 (de) 1991-10-10
EP0445894B1 (en) 1995-02-08
EP0445894A2 (en) 1991-09-11
DE69107226D1 (de) 1995-03-23
AU7281091A (en) 1991-09-12
GB2241891B (en) 1994-05-25
GB9104927D0 (en) 1991-04-24
FR2659235A1 (fr) 1991-09-13
GR3015840T3 (en) 1995-07-31
ATE118221T1 (de) 1995-02-15

Similar Documents

Publication Publication Date Title
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
DE69232334D1 (de) Substituierte 3-aminochinuclidine
MX9200361A (es) Nuevo uso del antagonista de adenosina.
ATE211729T1 (de) Therapeutisch wirksame verbindungen
CA2041417A1 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
CA2046069A1 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
EA199901116A1 (ru) Композиция, включающая 5-[4-[2-(n-метил-n-2-пиридил)-амино)этокси]бензил]тиазолидин-2,4-дион
DK0445894T3 (da) Anvendelse af tumornekrosefaktor
EA199800417A1 (ru) Фармацевтическая композиция для лечения аутоиммунных заболеваний
DK658889A (da) Farmaceutisk praeparat til brug ved behandling af psoriasis
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
PT1017681E (pt) Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios
CA2041240A1 (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
DK0523013T3 (da) Anvendelse af benzimidazolin-2-oxo-1-carboxylsyrederivater ved behandling af organiske mentale sygdomme
FI890173A (fi) Isoxazoler med nootropisk verkan.
IT1248669B (it) Derivato di idrossiprolina, sua preparazione e composizioni farmaceutiche che lo contengono
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
DK0488044T3 (da) En imidazobenzodiazepin til behandling af søvnforstyrrelser
IT9019356A1 (it) Composizioni galeniche adatte per la somministrazione nasale a base di eritropoietina, per il trattamento delle anemie